Monoclonal gammopathy of uncertain significance (MGUS) may present the clinician with diagnostic difficulties. This paper reviews the literature relating to MGUS, presents findings of a local prevalence study, and provides advice on monitoring.
KyleRA. Monoclonal gammopathy of undetermined significance — natural history in 241 cases. Am J Med1978; 64: 814–826.
3.
AxelssonV, BachmannR, HallenJ.Frequency of pathological proteins (M-components) in 6995 sera from adult population. Acta Med Scand1966; 179: 235–246.
4.
KyleRA, FinkelsteinS, ElvebackLR, KurlandLT. Incidence of monoclonal proteins in Minnesota community with a cluster of multiple myeloma. Blood1972; 40: 719–724.
5.
WaldenstromJ.Monoclonal gammopathy — A difficult clinical problem. Acta Med Scand1983; 214: 257–258.
6.
YoungVH. Transient paraproteinaemia. Proceedings of Royal Society of Medicine1969; 62: 778–780.
7.
BernettA, AllerhandJ, EfremidesAP, ClejanS.Long-term study of gammopathies. Clinically benign cases showing transition to malignant plasmacytomas after long periods of observation. Clin Biochem1986; 19: 244–249.
8.
RitzmanSE, DanielsJC. Serum electrophoresis and total serum proteins. In: RitzmanS, DanielsJ. Eds. Serum protein abnormalities: Diagnostic and clinical aspects. Boston: Little, Brown1975: 3–26.
